← Evidence map

ArticleFrontiers in oncology2024

Commentary: Serum EZH2 is a novel biomarker for bladder cancer diagnosis and prognosis.

Tao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39381038